Search results
- 1.0586069 - BTÚ 2025 RIV GB eng J - Journal Article
Beerkens, A. P. M. - Boreel, D. F. - Nathan, J. A. - Neužil, Jiří - Cheng, G. - Kalyanaraman, B. - Hardy, M. - Adema, G. J. - Heskamp, S. - Span, Paul N. - Bussink, J.
Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging.
Cancer & Metabolism. Roč. 12, č. 1 (2024), č. článku 13. E-ISSN 2049-3002
Institutional support: RVO:86652036
Keywords : oxidative-phosphorylation * cancer * mitochondria * dehydrogenase * oxygen
OECD category: Oncology
Impact factor: 5.9, year: 2022
Method of publishing: Open access
https://cancerandmetabolism.biomedcentral.com/articles/10.1186/s40170-024-00342-6
Permanent Link: https://hdl.handle.net/11104/0354418 - 2.0582380 - BTÚ 2025 US eng J - Journal Article
Sharma, P. - Maklashina, E. - Voehler, M. - Balintová, Soňa - Dvořáková, Šárka - Kraus, Michal - Váňová Hadrava, Kateřina - Nahácka, Zuzana - Zobalová, Renata - Boukalová, Štěpána - Čunátová, Kristýna - Mráček, Tomáš - Ghayee, H. K. - Pacak, K. - Rohlena, Jakub - Neužil, Jiří - Cecchini, G. - Iverson, T. M.
Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners.
Nature Communications. Roč. 15, č. 1 (2024), č. článku 473. E-ISSN 2041-1723
R&D Projects: GA MZd(CZ) NU23-03-00226; GA ČR(CZ) GA23-05303S; GA ČR(CZ) GJ20-11724Y; GA ČR GA19-20553S; GA ČR(CZ) GX21-04607X; GA ČR(CZ) GA20-05942S; GA ČR(CZ) GA20-25768S
Institutional support: RVO:86652036 ; RVO:67985823
Keywords : onset optic atrophy * succinate-dehydrogenase * crystal-structure * structural basis * chemical-shifts
OECD category: Biochemistry and molecular biology; Cell biology (FGU-C)
Impact factor: 16.6, year: 2022
Method of publishing: Open access
https://www.nature.com/articles/s41467-023-44563-7
Permanent Link: https://hdl.handle.net/11104/0353431 - 3.0576613 - BTÚ 2024 RIV GB eng J - Journal Article
Bielcikova, Z. - Werner, Lukáš - Štursa, Jan - Černý, V. - Křížová, L. - Špaček, J. - Hlousek, S. - Vočka, M. - Bartosova, O. - Pesta, M. - Kološtová, K. - Klezl, P. - Bobek, V. - Truksa, Jaroslav - Štemberková-Hubáčková, Soňa - Petruzelka, L. - Michálek, P. - Neužil, Jiří
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial.
Therapeutic Advances in Medical Oncology. Roč. 15, March 28 (2023), č. článku 17588359231197957. ISSN 1758-8340. E-ISSN 1758-8359
R&D Projects: GA MZd(CZ) NU21-03-00545
Keywords : case series * efficacy * mechanism of action * mitocans * mitochondria
OECD category: Oncology
Impact factor: 4.9, year: 2022
Method of publishing: Open access
https://journals.sagepub.com/doi/10.1177/17588359231197957
Permanent Link: https://hdl.handle.net/11104/0347246 - 4.0572870 - BTÚ 2024 RIV NL eng J - Journal Article
Bielcikova, Z. - Štursa, Jan - Křížová, L. - Dong, L. - Špaček, J. - Hlousek, S. - Vocka, M. - Rohlenová, Kateřina - Bartosova, O. - Černý, V. - Padrta, T. - Pesta, M. - Michálek, P. - Hubáčková, Soňa - Kološtová, K. - Pospíšilová, E. - Bobek, V. - Klezl, P. - Zobalová, Renata - Endaya, Berwini - Rohlena, Jakub - Petruzelka, L. - Werner, Lukáš - Neužil, Jiří
Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial.
ECLINICALMEDICINE. Roč. 57, MAR 2023 (2023), č. článku 101873. E-ISSN 2589-5370
Institutional support: RVO:86652036
Keywords : Phase I * Ib clinical trial * Cancer * Mitochondrially targeted tamoxifen * Renal cell carcinoma
OECD category: General and internal medicine
Impact factor: 15.1, year: 2022
Method of publishing: Open access
https://www.sciencedirect.com/science/article/pii/S2589537023000500?via%3Dihub
Permanent Link: https://hdl.handle.net/11104/0343476 - 5.0568951 - BTÚ 2024 RIV US eng J - Journal Article
Oh, S. - Jo, S. - Kim, H. S. - Mai, V. - Endaya, B. - Neužil, Jiří - Jung, K. H. - Hong, S. - Kim, J. - Park, S.
Chemical Biopsy for GNMT as Noninvasive and Tumorigenesis-Relevant Diagnosis of Liver Cancer.
Analytical Chemistry. Roč. 95, č. 2 (2023), s. 1184-1192. ISSN 0003-2700. E-ISSN 1520-6882
Institutional support: RVO:86652036
Keywords : GLYCINE N-METHYLTRANSFERASE * INFILTRATIVE HEPATOCELLULAR-CARCINOMA * FOLATE-BINDING-PROTEIN
OECD category: Analytical chemistry
Impact factor: 7.4, year: 2022
Method of publishing: Limited access
https://pubs.acs.org/doi/full/10.1021/acs.analchem.2c03944
Permanent Link: https://hdl.handle.net/11104/0347904 - 6.0556526 - BTÚ 2023 RIV GB eng J - Journal Article
Štemberková-Hubáčková, Soňa - Zobalová, Renata - Dubišová, Maria - Šmigová, J. - Dvořáková, Šárka - Kořínková, Klára - Ezrová, Zuzana - Endaya, Berwini - Blažková, Kristýna - Vlčák, Erik - Brisudová, Petra - Le, Dan-Diem Thi - Juhás, Štefan - Rosel, D. - Kelemen, Daniela Cristina - Sovilj, Dana - Vačurová, Eliška - Čajka, Tomáš - Filimonenko, Vlada - Dong, L. - Anděra, Ladislav - Hozák, Pavel - Brabek, J. - Bielcikova, Z. - Štursa, Jan - Werner, Lukáš - Neužil, Jiří
Simultaneous targeting of mitochondrial metabolism and immune checkpoints as a new strategy for renal cancer therapy.
Clinical and Translational Medicine. Roč. 12, č. 3 (2022), č. článku e645. ISSN 2001-1326. E-ISSN 2001-1326
R&D Projects: GA ČR(CZ) GA20-05942S; GA ČR(CZ) GX21-04607X; GA ČR(CZ) GA18-02550S; GA ČR(CZ) GA19-08772S; GA MZd NU21-03-00195; GA MŠMT(CZ) LM2018129; GA MŠMT(CZ) ED1.1.00/02.0109; GA MŠMT LTC19048; GA MŠMT(CZ) LO1609; GA MŠMT(CZ) EF16_013/0001775
Grant - others:AV ČR(CZ) StrategieAV21/18
Program: StrategieAV
Institutional support: RVO:86652036 ; RVO:68378050 ; RVO:67985904 ; RVO:67985823
Keywords : Mitochondrially targeted tamoxifen * Renal cancer * Immunotherapy
OECD category: Pathology
Impact factor: 10.6, year: 2022
Method of publishing: Open access
https://onlinelibrary.wiley.com/doi/10.1002/ctm2.645
Permanent Link: http://hdl.handle.net/11104/0331774 - 7.0550581 - BTÚ 2023 RIV CH eng J - Journal Article
Raghavan, A. - Rao, P. - Neužil, Jiří - Pountney, D. L. - Nath, S.
Oxidative stress and Rho GTPases in the biogenesis of tunnelling nanotubes: implications in disease and therapy.
Cellular and Molecular Life Sciences. Roč. 79, č. 1 (2022). ISSN 1420-682X. E-ISSN 1420-9071
Institutional support: RVO:86652036
Keywords : mesenchymal stem-cells * fibrillar alpha-synuclein * multipotent stromal cells * mitochondrial transfer * in-vitro * membrane nanotubes
OECD category: Biochemistry and molecular biology
Impact factor: 8, year: 2022
Method of publishing: Open access
https://link.springer.com/article/10.1007/s00018-021-04040-0
Permanent Link: http://hdl.handle.net/11104/0331072